EMPA-REG: Glucose excretion and lipid mobilization – not storage – saves lives
Author:
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference9 articles.
1. The EMPA-REG study: What has it told us? A diabetologist’s perspective;DeFronzo;Journal of Diabetes and its Complications,2016
2. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients;Ferrannini;Journal of Clinical Investigation,2014
3. Decreased long-chain fatty acid oxidation impairs postischemic recovery of the insulin-resistant rat heart;Harmancey;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology,2013
4. Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin;Masi;Diabetologia,2012
5. Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-18F-fluoro-4-thiapalmitate, a novel PET fatty acid tracer;Mather;American Journal of Physiology. Endocrinology and Metabolism,2016
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator;Cardiovascular Diabetology;2024-01-06
2. Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial;BMJ Open;2022-08
3. Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure;Circulation: Heart Failure;2020-01
4. Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats;Nature Communications;2019-02-01
5. Empagliflozin reduces blood pressure and uric acid in patients with type 2 diabetes mellitus: a systematic review and meta-analysis;Journal of Human Hypertension;2018-11-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3